Extracorporeal Membrane Oxygenation Machine Market challenges and opportunities
According to research report Extracorporeal Membrane Oxygenation Machine Market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%.
Ask For Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=255167654
A
number of factors such as the growing cardiovascular and respiratory
diseases, rising adoption of ECMO as a bridge to heart & lung
transplantation, growing number of ECMO centers, conferences and
training programs to increase awareness, and technological advancements
are the significant factors driving the growth of the Extracorporeal
Membrane Oxygenation Machine Market. In addition, the growing aging
population and the number of people suffering from cardiopulmonary
diseases in populous countries such as India and China are factors that
are expected to offer significant growth opportunities for ECMO systems.
Complications associated with ECMO
• Bleeding: This is
the most common complication associated with the use of ECMO. Bleeding
mainly occurs due to a drug called Heparin, which is used for blood
thinning. According to a study published by NCBI in 2013, about 23% of
patients undergoing ECMO suffered severe bleeding. Managing the relative
risks of bleeding and thrombosis is difficult as many factors related
to the patient’s illness, extracorporeal support, and balance of
pro-inflammatory and anti-inflammatory pathways differ between patients.
•
Infection: Infections are more prone to occur when a cannula is
inserted into the blood vessels. Also, when a patient is admitted in a
hospital for a longer duration (more than 15 days), the probability of
the patient contracting hospital-acquired infections increases.
According to a study conducted by NCBI, bloodstream infection was one of
the most common complications occurring in ~14.4% of patients on ECMO.
•
Technical Failures: Air within the ECMO circuit causes up to 4% of
mechanical failures. Pump failures are caused due to motor malfunction
or power outage as well as inadequate venous return.
Based on
application, the global ECMO machine market is segmented into
Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation
(ECPR). The respiratory segment is estimated to account for the largest
share of the market in 2016. The large share of this segment can be
attributed to factors such as rising incidence of respiratory failure,
lung cancer, and lung transplants, and increasing adoption of ECMO.
Based
on the modality, the global ECMO machine market is segmented into
venoarterial (VA), venovenous (VV), and arteriovenous (AV). The
venovenous (VV) segment is estimated to account for the largest share of
the global market in 2016, and venoarterial (VA) segment is projected
to grow at the highest CAGR in the forecast period.
On the basis
of region, the global Extracorporeal Membrane Oxygenation Machine Market
is divided into North America, Europe, Asia-Pacific, and the Rest of
the World (RoW). In 2016, North America accounted for the largest share
of the market, followed by Europe, Asia-Pacific, and the Rest of the
World. The Asia-Pacific market is projected to grow at the highest CAGR
and serve as a revenue pocket for companies offering ECMO systems.
Request Free Report Sample: http://www.marketsandmarkets.com/requestsample.asp?id=255167654
Comments
Post a Comment